Search clinical trials for: Contact lense wearers

Total 5828 results

Eli Lilly and Company
Boehringer Ingelheim

Completed

Duloxetine Compared With Placebo in the Prevention of Relapse in Generalized Anxiety Disorder

Anxiety Disorders

United States, Austria, France, Germany, Netherlands, Portugal, Puerto Rico
Eli Lilly and Company
Boehringer Ingelheim

Completed

Duloxetine Versus Placebo in the Treatment of FMS

Fibromyalgia

United States, Spain, Puerto Rico, Germany, United Kingdom, Sweden
Guidant Corporation

Terminated

REBEAT Resynchronisation and Beta-Blocker European Trial

Heart Failure

Switzerland, Italy
Eli Lilly and Company

Completed

Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve Pain

Diabetic Neuropathy, Painful

United States, Puerto Rico
Eli Lilly and Company

Completed

Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With Depression

Depression

United States
Eli Lilly and Company

Completed

Observational Study of Pergolide Mesylate and Cardiac Valvulopathy

Parkinson Disease

Italy, France, Belgium, Germany
Eli Lilly and Company

Completed

Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia

Schizophrenia

United States
Eli Lilly and Company

Completed

2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis

Osteoporosis, Postmenopausal

Germany
Eli Lilly and Company

Completed

Duloxetine Versus Duloxetine Plus Non-Drug Therapy for Depression

Depression

Austria
Eli Lilly and Company

Completed

Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily Insulin

Type 2 Diabetes Mellitus

United States, Spain, United Kingdom
Eli Lilly and Company

Completed

Neoadjuvant Chemo (Gemcitabine and Cisplatin) With Radical Cystectomy or Radiotherapy in Patients With Bladder Cancer

Bladder Cancer

Poland
Eli Lilly and Company

Completed

Intravesical Chemotherapy Treatment of Superficial Bladder Cancer

Bladder Neoplasms

Italy
Eli Lilly and Company

Completed

Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes

Non-Small Cell Lung Cancer

Poland
Eli Lilly and Company

Completed

Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

Spain
Eli Lilly and Company

Completed

Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian Cancer

Epithelial Ovarian Cancer

Slovakia
Eli Lilly and Company

Completed

Trial of Pemetrexed for Patients With Pancreatic Cancer Which Cannot be Treated With Surgery or is Metastatic

Pancreatic Cancer

Germany
Eli Lilly and Company

Completed

Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract Carcinomas

Biliary Tract Carcinoma

Korea, Republic of
Eli Lilly and Company

Completed

Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency

Hypopituitarism

United States, France, Germany, Italy, Puerto Rico, United Kingdom
Eli Lilly and Company

Completed

Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy

Non-Small Cell Lung Cancer

Germany, Italy, United Kingdom
Eli Lilly and Company

Completed

Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in Patients With Schizophrenia

Schizophrenic Disorders

Turkey, Finland
Eli Lilly and Company

Completed

Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung Cancer

Non-Small Cell Lung Cancer

China
Eli Lilly and Company

Completed

Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer

Breast Cancer

Argentina, Belgium, Germany, Romania, Spain, United Kingdom
Eli Lilly and Company

Completed

Duloxetine Versus Paroxetine for Major Depression

Major Depressive Disorder

China
Eli Lilly and Company

Completed

Duloxetine Versus Placebo for Fibromyalgia

Fibromyalgia

United States
Eli Lilly and Company

Completed

Growth Hormone Treatment in Short Children Born Small for Gestational Age

Infant, Small for Gestational Age

Germany
Eli Lilly and Company

Completed

Evaluation of Continuous Symptom Treatment of ADHD

Attention Deficit Hyperactivity Disorder

United States
Eli Lilly and Company

Completed

Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHD

Attention Deficit Hyperactivity Disorder

China, Mexico, Korea, Republic of
Eli Lilly and Company

Completed

Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With Schizophrenia

Schizophrenia

Japan
Eli Lilly and Company

Completed

Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics

Schizophrenia

China
Eli Lilly and Company

Completed

Comparison of Atomoxetine Plus Either Comparator or Placebo in Children With ADHD Who Haven't Responded to Stimulant Therapy

Attention Deficit Hyperactivity Disorder

United States
Eli Lilly and Company

Completed

Safety Study in Outpatient Japanese Children With ADHD

Attention Deficit Hyperactivity Disorder

Japan
Eli Lilly and Company

Completed

A Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviour Problems in Children With ASD

Attention Deficit Hyperactivity Disorder

Netherlands
Eli Lilly and Company

Completed

Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I Depression

Bipolar Disorder

United States
Eli Lilly and Company

Completed

Atomoxetine Hydrochloride Versus Placebo in Taiwanese Children and Adolescents With ADHD

Attention Deficit Hyperactivity Disorder

Taiwan
Eli Lilly and Company

Completed

Olanzapine Versus Comparator in the Treatment of Bipolar Disorder

Bipolar Disorder

China
Eli Lilly and Company

Completed

Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With Schizophrenia

Schizophrenia

Taiwan
Eli Lilly and Company

Completed

Weight Gain Management in Patients With Schizophrenia

Schizophrenia

Brazil
Eli Lilly and Company

Completed

Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia

Schizophrenic Disorders

Korea, Republic of
Eli Lilly and Company

Completed

Safety and Efficacy of Switching From a Stimulant Medication to Atomoxetine in Children and Adolescents With ADHD

Attention Deficit Hyperactivity Disorder

United States
Eli Lilly and Company

Completed

Combination Therapy in Patients With Depression

Depressive Symptoms

United States
Eli Lilly and Company

Completed

Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder

Bipolar Disorder

United States
Eli Lilly and Company

Completed

Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial

Postmenopausal Osteoporosis

Germany, Spain, Greece, Mexico, Israel, Czech Republic
Eli Lilly and Company

Completed

Comparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With Schizophrenia

Schizophrenia

United States, Russian Federation, Croatia
Eli Lilly and Company

Completed

Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia

Schizophrenia

United States, Russian Federation
Eli Lilly and Company

Completed

Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Disorder With Hyperactivity

Russian Federation
Eli Lilly and Company

Completed

Evaluation of the Effects of Duloxetine on Norepinephrine

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

A Study Using Rapid Acting Intramuscular Olanzapine in Agitated Patients With Schizophrenia

Schizophrenia

Japan
Eli Lilly and Company

Completed

Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder

Attention Deficit Hyperactivity Disorder | Comorbid Social Anxiety Disorder

United States, Puerto Rico
Eli Lilly and Company

Completed

Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS) (LEAPS)

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

Effects of LY450139 Dihydrate on Subjects With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States

3

Subscribe